A detailed history of Diligent Investors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Diligent Investors, LLC holds 448 shares of LLY stock, worth $457,721. This represents 0.1% of its overall portfolio holdings.

Number of Shares
448
Previous 367 22.07%
Holding current value
$457,721
Previous $286,000 19.23%
% of portfolio
0.1%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$625.65 - $812.69 $50,677 - $65,827
81 Added 22.07%
448 $341,000
Q2 2025

Jul 21, 2025

BUY
$713.71 - $898.95 $261,931 - $329,914
367 New
367 $286,000
Q1 2024

May 03, 2024

SELL
$592.2 - $792.28 $22,503 - $30,106
-38 Reduced 7.57%
464 $360,000
Q2 2023

Jul 24, 2023

BUY
$350.74 - $468.98 $176,071 - $235,427
502 New
502 $235,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Diligent Investors, LLC Portfolio

Follow Diligent Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diligent Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Diligent Investors, LLC with notifications on news.